674 related articles for article (PubMed ID: 16818675)
1. A crucial role for interleukin (IL)-1 in the induction of IL-17-producing T cells that mediate autoimmune encephalomyelitis.
Sutton C; Brereton C; Keogh B; Mills KH; Lavelle EC
J Exp Med; 2006 Jul; 203(7):1685-91. PubMed ID: 16818675
[TBL] [Abstract][Full Text] [Related]
2. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity.
Sutton CE; Lalor SJ; Sweeney CM; Brereton CF; Lavelle EC; Mills KH
Immunity; 2009 Aug; 31(2):331-41. PubMed ID: 19682929
[TBL] [Abstract][Full Text] [Related]
3. CCR7 ligands are required for development of experimental autoimmune encephalomyelitis through generating IL-23-dependent Th17 cells.
Kuwabara T; Ishikawa F; Yasuda T; Aritomi K; Nakano H; Tanaka Y; Okada Y; Lipp M; Kakiuchi T
J Immunol; 2009 Aug; 183(4):2513-21. PubMed ID: 19625643
[TBL] [Abstract][Full Text] [Related]
4. CD4+ICOS+ T lymphocytes inhibit T cell activation 'in vitro' and attenuate autoimmune encephalitis 'in vivo'.
Rojo JM; Pini E; Ojeda G; Bello R; Dong C; Flavell RA; Dianzani U; Portolés P
Int Immunol; 2008 Apr; 20(4):577-89. PubMed ID: 18310064
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of ERK MAPK suppresses IL-23- and IL-1-driven IL-17 production and attenuates autoimmune disease.
Brereton CF; Sutton CE; Lalor SJ; Lavelle EC; Mills KH
J Immunol; 2009 Aug; 183(3):1715-23. PubMed ID: 19570828
[TBL] [Abstract][Full Text] [Related]
6. Do Th2 cells mediate the effects of glatiramer acetate in experimental autoimmune encephalomyelitis?
Jee Y; Liu R; Bai XF; Campagnolo DI; Shi FD; Vollmer TL
Int Immunol; 2006 Apr; 18(4):537-44. PubMed ID: 16481342
[TBL] [Abstract][Full Text] [Related]
7. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
Samoilova EB; Horton JL; Hilliard B; Liu TS; Chen Y
J Immunol; 1998 Dec; 161(12):6480-6. PubMed ID: 9862671
[TBL] [Abstract][Full Text] [Related]
8. IL-1beta, but not IL-1alpha, is required for antigen-specific T cell activation and the induction of local inflammation in the delayed-type hypersensitivity responses.
Nambu A; Nakae S; Iwakura Y
Int Immunol; 2006 May; 18(5):701-12. PubMed ID: 16569679
[TBL] [Abstract][Full Text] [Related]
9. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice.
Bettelli E; Das MP; Howard ED; Weiner HL; Sobel RA; Kuchroo VK
J Immunol; 1998 Oct; 161(7):3299-306. PubMed ID: 9759845
[TBL] [Abstract][Full Text] [Related]
10. Interleukin 18-independent engagement of interleukin 18 receptor-alpha is required for autoimmune inflammation.
Gutcher I; Urich E; Wolter K; Prinz M; Becher B
Nat Immunol; 2006 Sep; 7(9):946-53. PubMed ID: 16906165
[TBL] [Abstract][Full Text] [Related]
11. Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.
Batten M; Li J; Yi S; Kljavin NM; Danilenko DM; Lucas S; Lee J; de Sauvage FJ; Ghilardi N
Nat Immunol; 2006 Sep; 7(9):929-36. PubMed ID: 16906167
[TBL] [Abstract][Full Text] [Related]
12. Pathophysiology of interleukin-23 in experimental autoimmune encephalomyelitis.
Touil T; Fitzgerald D; Zhang GX; Rostami AM; Gran B
Drug News Perspect; 2006 Mar; 19(2):77-83. PubMed ID: 16628262
[TBL] [Abstract][Full Text] [Related]
13. Critical role of preproenkephalin in experimental autoimmune encephalomyelitis.
Weir C; McNeill A; Hook S; Harvie M; La Flamme AC; Le Gros G; Bäckström BT
J Neuroimmunol; 2006 Oct; 179(1-2):18-25. PubMed ID: 16904193
[TBL] [Abstract][Full Text] [Related]
14. CXCL12 (SDF-1alpha) suppresses ongoing experimental autoimmune encephalomyelitis by selecting antigen-specific regulatory T cells.
Meiron M; Zohar Y; Anunu R; Wildbaum G; Karin N
J Exp Med; 2008 Oct; 205(11):2643-55. PubMed ID: 18852294
[TBL] [Abstract][Full Text] [Related]
15. IL-17 production from activated T cells is required for the spontaneous development of destructive arthritis in mice deficient in IL-1 receptor antagonist.
Nakae S; Saijo S; Horai R; Sudo K; Mori S; Iwakura Y
Proc Natl Acad Sci U S A; 2003 May; 100(10):5986-90. PubMed ID: 12721360
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-1 drives pathogenic Th17 cells during spontaneous arthritis in interleukin-1 receptor antagonist-deficient mice.
Koenders MI; Devesa I; Marijnissen RJ; Abdollahi-Roodsaz S; Boots AM; Walgreen B; di Padova FE; Nicklin MJ; Joosten LA; van den Berg WB
Arthritis Rheum; 2008 Nov; 58(11):3461-70. PubMed ID: 18975337
[TBL] [Abstract][Full Text] [Related]
17. IL-23-driven encephalo-tropism and Th17 polarization during CNS-inflammation in vivo.
Gyülvészi G; Haak S; Becher B
Eur J Immunol; 2009 Jul; 39(7):1864-9. PubMed ID: 19544494
[TBL] [Abstract][Full Text] [Related]
18. IL-1 and TNF receptor-deficient mice show decreased inflammation in an immune complex model of uveitis.
Brito BE; O'Rourke LM; Pan Y; Anglin J; Planck SR; Rosenbaum JT
Invest Ophthalmol Vis Sci; 1999 Oct; 40(11):2583-9. PubMed ID: 10509653
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic efficacy of IL-17 neutralization in murine experimental autoimmune encephalomyelitis.
Hofstetter HH; Ibrahim SM; Koczan D; Kruse N; Weishaupt A; Toyka KV; Gold R
Cell Immunol; 2005 Oct; 237(2):123-30. PubMed ID: 16386239
[TBL] [Abstract][Full Text] [Related]
20. CD28-dependent differentiation into the effector/memory phenotype is essential for induction of arthritis in interleukin-1 receptor antagonist-deficient mice.
Kotani M; Hirata K; Ogawa S; Habiro K; Ishida Y; Tanuma S; Horai R; Iwakura Y; Kishimoto H; Abe R
Arthritis Rheum; 2006 Feb; 54(2):473-81. PubMed ID: 16453283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
